Cannabis
Radient Announces Update on Trading Reinstatement
Edmonton, Alberta–(Newsfile Corp. – April 3, 2023) – Radient Technologies Inc. (TSXV: RTI) (OTCQX: RDDTF) (“Radient” or the “Company“) is pleased to announce that the Company has applied to the TSX Venture Exchange (the “TSXV“) to reinstate trading of its common shares and is preparing responses to the TSXV’s enquiries and compiling the requisite materials.
As previously announced on March 30, 2023, the Alberta Securities Commission granted Radient a revocation order respecting a failure-to-file cease trade order (“FFCTO“) that has been in effect since March 7, 2023. The revocation order also evidences the decision of the Ontario Securities Commission. The issuance of the revocation order follows the filing by Radient of its interim financial statements for the nine-month period ended December 31, 2022, and the related Management’s Discussion and Analysis and Certifications on March 22, 2023. On March 8, 2023, following the issuance of the FFCTO, the TSXV suspended trading of the Company’s common shares.
The Company would like to thank its shareholders and supporters for their patience at this time and confirms that it will endeavour to issue regular press releases to keep investors apprised of the situation, including of any anticipated trading resumption timeline.
About Radient
Radient is a commercial manufacturer of diverse, novel and high-quality cannabis extracts and packaged products. Radient develops specialty products and ingredients that contain a broad range of cannabinoid and terpene profiles while meeting the highest standards of quality and safety. Radient is focused on innovation with expertise in formulations and technologies offering unique solutions in the cannabis and wellness space. Please visit www.radientinc.com for more information.
For more information, please contact:
Steven Splinter, CEO & Director
[email protected]
Ph: 780 465 1318
NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/161168
-
Cannabis1 week ago
Mikra Announces Partnership with Virun NutraBiosciences Inc. and Releases CELLF 2.0
-
Cannabis2 weeks ago
IM Cannabis Reports First Quarter Financial Results
-
Innocan1 week ago
Innocan Pharma Reports Breakthrough in a Pre-Clinical Trial: Liposomal-CBD Injection Restores Mobility to an Amputee Female Donkey
-
Cannabis6 days ago
Global Legal Marijuana Strategic Business Report 2024: A $125+ Billion Market by 2030 Featuring Aphria, Aurora Cannabis, Beacon Medical, Canopy Growth, Cronos, OrganiGram, Tikun Olam, Tilray, Wayland
-
Cannabis6 days ago
Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa
-
SCHWAZZE3 days ago
Schwazze Announces First Quarter 2024 Financial Results
-
Cannabis5 days ago
North America Legal Cannabis Industry Report 2024: Market to Grow at a CAGR of 26.65% During 2023-2032, Bank Loans Boosting Business Growth
-
Cannabis4 days ago
Polyethylene Films Packaging Market Size to Worth USD 139.98 Bn by 2032